Trials / Conditions / Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia
3 registered clinical trials studyying Philadelphia Chromosome Negative, BCR-ABL1 Positive Chronic Myelogenous Leukemia.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | ABL001 for the Treatment of Chronic Myeloid Leukemia in Patients Who Are on Therapy With Tyrosine Kinase Inhib NCT04216563 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Belinostat and Azacitidine in Treating Patients With Advanced Hematologic Cancers or Other Diseases NCT00351975 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Sorafenib in Treating Young Patients With Relapsed or Refractory Solid Tumors or Leukemia NCT01445080 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |